PaQ®, a simple 3-day basal/bolus insulin delivery device, may optimise insulin delivery in type 2 diabetes as determined by continuous glucose monitoring

被引：0
|
作者：
Mazze, R. [1 ]
Strock, E. [1 ]
Mader, J. [2 ]
Lilly, L. [3 ]
Aberer, F. [2 ]
Pieber, T. [2 ]
机构：
[1] Int Diabet Ctr, Minneapolis, MN USA
[2] Graz Univ, A-8010 Graz, Austria
[3] CeQur, Marlborough, MA USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1005
引用
收藏
页码：S413 / S413
页数：1
相关论文
共 50 条
  • [21] Insulin kinetics in type-1 diabetes: Continuous and bolus delivery of rapid acting insulin
    Wilinska, ME
    Chassin, LJ
    Schaller, HC
    Schaupp, L
    Pieber, TR
    Hovorka, R
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2005, 52 (01) : 3 - 12
  • [22] Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
    Bergenstal, Richard M.
    Peyrot, Mark
    Dreon, Darlene M.
    Aroda, Vanita R.
    Bailey, Timothy S.
    Brazg, Ronald L.
    Frias, Juan P.
    Johnson, Mary L.
    Klonoff, David C.
    Kruger, Davida F.
    Ramtoola, Shenaz
    Rosenstock, Julio
    Serusclat, Pierre
    Weinstock, Ruth S.
    Naik, Ramachandra G.
    Shearer, David M.
    Zraick, Vivien
    Levy, Brian L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (05) : 273 - 285
  • [23] The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery
    Castaneda, Javier
    de Galan, Bastiaan E.
    van Kuijk, Sander M. J.
    Arrieta, Arcelia
    van den Heuvel, Tim
    Cohen, Ohad
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5836 - 5844
  • [24] Optimising basal-bolus therapy in type 2 diabetes: a randomised, controlled trial comparing bolus insulin delivery using an insulin patch vs an insulin pen
    Ramtoola, S.
    Aroda, V. R.
    Bailey, T. S.
    Brazg, R. L.
    Dreon, D. M.
    Frias, J. P.
    Klonoff, D. C.
    Kruger, D. F.
    Levy, B. L.
    Peyrot, M.
    Rosenstock, J.
    Serusclat, P.
    Weinstock, R. S.
    Zraicks, V.
    Bergenstal, R. M.
    DIABETOLOGIA, 2018, 61 : S397 - S397
  • [25] Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 Diabetes
    Aronson, Ronnie
    Mahoney, Edward
    Saliu, Drilon
    Sze, David
    Morel, Didier
    Bergquist, Leya
    Hirsch, Laurence
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (05) : 352 - 359
  • [26] Continuous Glucose Monitoring Improves Glycemic Control in Subjects With Type 2 Diabetes on Basal Insulin
    Manning, James P.
    Halford, Jean R.
    Liljenquist, David R.
    Sulik, Mark B.
    Sulik, Rebecca T.
    DIABETES, 2012, 61 : A587 - A587
  • [27] Effectiveness of Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes Treated with Basal Insulin
    Bao, Shichun
    Bailey, Ryan
    Calhoun, Peter
    Beck, Roy W.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (05) : 299 - 306
  • [28] Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
    Hernandez-Nunez, Wellbert
    Villareal-Perez, Jesus Zacarias
    Rodriguez-Gutierrez, Rene
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (13): : 1330 - 1330
  • [29] Optimization of basal insulin delivery in Type 1 diabetes:: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine
    Fahlén, M
    Eliasson, B
    Odén, A
    DIABETIC MEDICINE, 2005, 22 (04) : 382 - 386
  • [30] EFFICACY AND SAFETY OF BASAL BOLUS INSULIN REGIMEN IN A COHORT OF TYPE 2 DIABETES PATIENTS HOSPITALIZED IN GENERAL WARD ASSESSED BY CONTINUOUS GLUCOSE MONITORING
    Gomez, A. M.
    Henao Carrillo, D. C.
    Imitola Madero, A.
    Munoz, O. M.
    Rondon, M.
    Robledo, M. A.
    Rebolledo, M.
    Umpierrez, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A67 - A68
12345